Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial

Table 2 Patient characteristics

Characteristic		No. of patients		Percentage of Patients (%)
		N = 13
Gender
	Male	9		69.2
	Female	4		30.8
Age
	Median		65
	Range		57-75
Karnofsky performance status
	Median		80
	Range		70-90
Histology
	Squamous cell carcinoma	7		53.8
	Adenocarcinoma	6		46.2
Stage
	IIIA	6		46.2
	IIIB	7		53.8
GTV
	Median		84.6 cm³
	Range		22.3-222.5 cm³
PTV
	Median		234.9 cm³
	Range		111.6-369.7 cm³

ISSN: 1748-717X